PDCD1 and neoplasm: Expectedly, the majority of the tumor-infiltrating CD8+ T cells was stained with anti-rat IgG2a antibody, confirming the binding of anti-PD-1 antibody on the majority of the tumor-infiltrating CD8+ T cells (Figure 4E).